(Q39602815)

13 September 2017

An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China (English)

1 reference

Japanese encephalitis virus

13 September 2017

0 references

immunization

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Japanese encephalitis vaccine

1 reference

1 reference

Zundong Yin

1

1 reference

13 September 2017

Garrett R Beeler Asay

2

1 reference

13 September 2017

Li Zhang

3

1 reference

13 September 2017

Yixing Li

4

1 reference

13 September 2017

Shuyan Zuo

5

1 reference

13 September 2017

Yvan J Hutin

6

1 reference

13 September 2017

Guijun Ning

7

1 reference

13 September 2017

Hardeep S Sandhu

8

1 reference

13 September 2017

Lisa Cairns

9

1 reference

13 September 2017

Huiming Luo

10

1 reference

13 September 2017

Guizhou JE Study Group

11

1 reference

13 September 2017

language of work or name

English

0 references

publication date

12 June 2012

1 reference

13 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

13 September 2017

30

1 reference

13 September 2017

37

1 reference

13 September 2017

5569-5577

1 reference

Estimated global incidence of Japanese encephalitis: a systematic review

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

7 January 2021

Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

New Japanese encephalitis vaccines: alternatives to production in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Can insurance increase financial risk? The curious case of health insurance in China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

WHO Guide for standardisation of economic evaluations of immunization programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Tracking China's health reform.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

The Chinese health system at a crossroads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

Distribution of medical insurance in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.068

10.1016/J.VACCINE.2012.05.068

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference